220 related articles for article (PubMed ID: 28067429)
1. Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.
Olivos DJ; Alvarez M; Cheng YH; Hooker RA; Ciovacco WA; Bethel M; McGough H; Yim C; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
J Cell Biochem; 2017 Aug; 118(8):2231-2240. PubMed ID: 28067429
[TBL] [Abstract][Full Text] [Related]
2. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis.
Meijome TE; Ekwealor JTB; Hooker RA; Cheng YH; Ciovacco WA; Balamohan SM; Srinivasan TL; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
J Cell Biochem; 2016 Apr; 117(4):959-69. PubMed ID: 26375403
[TBL] [Abstract][Full Text] [Related]
3. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
4. A novel role for thrombopoietin in regulating osteoclast development in humans and mice.
Bethel M; Barnes CL; Taylor AF; Cheng YH; Chitteti BR; Horowitz MC; Bruzzaniti A; Srour EF; Kacena MA
J Cell Physiol; 2015 Sep; 230(9):2142-51. PubMed ID: 25656774
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocyte-mediated inhibition of osteoclast development.
Kacena MA; Nelson T; Clough ME; Lee SK; Lorenzo JA; Gundberg CM; Horowitz MC
Bone; 2006 Nov; 39(5):991-999. PubMed ID: 16782418
[TBL] [Abstract][Full Text] [Related]
6. Megakaryocyte-bone cell interactions.
Kacena MA; Ciovacco WA
Adv Exp Med Biol; 2010; 658():31-41. PubMed ID: 19950013
[TBL] [Abstract][Full Text] [Related]
7. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
8. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
9. A small interfering RNA targeting Lnk accelerates bone fracture healing with early neovascularization.
Kawakami Y; Ii M; Matsumoto T; Kawamoto A; Kuroda R; Akimaru H; Mifune Y; Shoji T; Fukui T; Asahi M; Kurosaka M; Asahara T
Lab Invest; 2013 Sep; 93(9):1036-53. PubMed ID: 23897412
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytes promote osteoclastogenesis in aging.
Kanagasabapathy D; Blosser RJ; Maupin KA; Hong JM; Alvarez M; Ghosh J; Mohamad SF; Aguilar-Perez A; Srour EF; Kacena MA; Bruzzaniti A
Aging (Albany NY); 2020 Jul; 12(14):15121-15133. PubMed ID: 32634116
[TBL] [Abstract][Full Text] [Related]
11. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
[TBL] [Abstract][Full Text] [Related]
12. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.
Bennett CN; Ouyang H; Ma YL; Zeng Q; Gerin I; Sousa KM; Lane TF; Krishnan V; Hankenson KD; MacDougald OA
J Bone Miner Res; 2007 Dec; 22(12):1924-32. PubMed ID: 17708715
[TBL] [Abstract][Full Text] [Related]
13. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2.
Kacena MA; Shivdasani RA; Wilson K; Xi Y; Troiano N; Nazarian A; Gundberg CM; Bouxsein ML; Lorenzo JA; Horowitz MC
J Bone Miner Res; 2004 Apr; 19(4):652-60. PubMed ID: 15005853
[TBL] [Abstract][Full Text] [Related]
14. A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells.
Kacena MA; Gundberg CM; Horowitz MC
Bone; 2006 Nov; 39(5):978-984. PubMed ID: 16860008
[TBL] [Abstract][Full Text] [Related]
15. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
16. The Multifarious Functions of Leukotrienes in Bone Metabolism.
Amadeu de Oliveira F; Tokuhara CK; Veeriah V; Domezi JP; Santesso MR; Cestari TM; Ventura TMO; Matos AA; Dionísio T; Ferreira MR; Ortiz RC; Duarte MAH; Buzalaf MAR; Ponce JB; Sorgi CA; Faccioli LH; Buzalaf CP; de Oliveira RC
J Bone Miner Res; 2023 Aug; 38(8):1135-1153. PubMed ID: 37314430
[TBL] [Abstract][Full Text] [Related]
17. Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss.
Granchi D; Torreggiani E; Massa A; Caudarella R; Di Pompo G; Baldini N
PLoS One; 2017; 12(7):e0181230. PubMed ID: 28715463
[TBL] [Abstract][Full Text] [Related]
18. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction.
Seita J; Ema H; Ooehara J; Yamazaki S; Tadokoro Y; Yamasaki A; Eto K; Takaki S; Takatsu K; Nakauchi H
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2349-54. PubMed ID: 17284614
[TBL] [Abstract][Full Text] [Related]
19. Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimen.
Zhu M; Sun BH; Nevius E; Kaplan J; Pereira J; Insogna K
PLoS One; 2021; 16(2):e0247199. PubMed ID: 33607650
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocyte and Osteoblast Interactions Modulate Bone Mass and Hematopoiesis.
Alvarez MB; Xu L; Childress PJ; Maupin KA; Mohamad SF; Chitteti BR; Himes E; Olivos DJ; Cheng YH; Conway SJ; Srour EF; Kacena MA
Stem Cells Dev; 2018 May; 27(10):671-682. PubMed ID: 29631496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
